GERD doesn't just involve the surface of the stomach. Thanks in part to PBMC supplied by HemaCare, researchers literally looked deeper.
Scientists have developed a method to track transplanted stem cells in the brain
Stem cell therapies have emerged as promising therapeutic options for treating many degenerative diseases including neurodegenerative diseases. The neurodegenerative diseases are characterized by the progressive degeneration of neurons. Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and Huntington’s disease are the most prevalent examples of neurodegenerative disorders. A variety of stem cells, including pluripotent embryonic stem cells, multipotent adult stem cells and induced pluripotent stem cells (iPSCs) have been utilized as therapeutic agents to treat many neurological disorders.
Scientists reprogrammed human pancreatic cancer cells to quiescent acinar like cells
Pancreatic ductal adenocarcinoma (PDA) is a fatal malignancy and one of the most difficult human cancers to treat. Medical science has made great strides in the early diagnosis and treatment of many other type of cancers such as breast cancer, prostate cancer, and lung cancer. However, the prognosis of pancreatic cancer remains an elusive clinical challenge largely because of the difficulty of making an early diagnosis. Patients with pancreatic cancer typically develop very few symptoms in the early stage, which could easily mislead physicians. The lethal nature of this cancer makes it the fourth leading cause of cancer death in the United States, with a median survival of less than 6 months and a dismal 5-years survival rate of 3%–5%. So far, no curative treatments are available to treat advanced stages of this disease. Surgery offers only a minimal chance to cure pancreatic cancer; however, less than 20% of patients diagnosed with pancreatic cancer are considered for surgical resection. Chemoradiotherapy and radiation have shown some success in reducing tumor growth and prolonging patients' life spans, but the beneficial effects of these treatments are limited in long run.
Researchers explore a new, less expensive option for manufacturing dendritic cells as cancer vaccines. HemaCare helped make it possible.
Precision medicine has become quite the catchphrase. In essence, it is an approach towards embracing medical therapy that is precise for the individual. One strategy relies on the patient’s genome. This entails pinpointing DNA mutations and proteins on patient biopsy samples using molecular diagnostics, as the same disease can have diverse causes in different patients. Such knowledge then leads to targeted therapy effective at the molecular level.
Scientists have developed an accelerated protocol to generate functional oligodendrocytes for the treatment of multiple sclerosis
In one of our previous blogs we have described that Multiple Sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS) characterized by brain inflammation, which arises when the nervous system is attacked by the body’s own immune cells. MS can develop because of viral infection, genetic defects or environmental factors. As yet, the exact etiology of the disease is unfortunately unknown.